Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
CELLDEX
Fourth Extension - Granted
Show more
Pharmaceutical preparations for the treatment of inflammation and inflammatory diseases; therapeutic antibodies for human use for the treatment of inflammation and inflammatory diseases; Pharmaceutical preparations for the treatment of cancer; therapeutic antibodies for human use for the treatment of cancer
Class 5 – Pharmaceuticals & supplements
Status timeline
- 17 Apr 2023Application filedNew Application Entered
- 9 Jan 2024Assigned to an examining attorneyAssigned To Examiner
- 9 Jan 2024Approved for publicationApproved For Pub - Principal Register
- 13 Feb 2024Published for oppositionPublished For Opposition
- 9 Apr 2024Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 11 Nov 2024Application abandoned — no statement of use filedAbandonment - No Use Statement Filed
- 12 Jun 2025Statement-of-use extension 1 grantedSou Extension 1 Granted
- 12 Jun 2025Statement-of-use extension 2 grantedSou Extension 2 Granted
- 4 Sep 2025Statement-of-use extension 3 grantedSou Extension 3 Granted
All 43 events
| 2026-04-04 | Notice Of Approval Of Extension Request E-Mailed |
| 2026-04-03 | Sou Teas Extension Received |
| 2026-04-03 | Sou Extension 4 Filed |
| 2026-04-03 | Sou Extension 4 Granted |
| 2026-01-16 | Applicant/Correspondence Changes (Non-Responsive) Entered |
| 2025-12-03 | Teas Post Publication Amendment Received |
| 2025-09-15 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-09-04 | Sou Teas Extension Received |
| 2025-09-04 | Sou Extension 3 Filed |
| 2025-09-04 | Sou Extension 3 Granted |
| 2025-07-10 | Teas Post Publication Amendment Received |
| 2025-07-10 | Amendment After Noa Not Entered |
| 2025-06-13 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-06-13 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-06-12 | Sou Extension 1 Granted |
| 2025-06-12 | Sou Extension 2 Granted |
| 2025-06-09 | Case Assigned To Intent To Use Paralegal |
| 2025-05-12 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2025-05-12 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2025-05-12 | Teas Change Of Correspondence Received |
| 2025-05-06 | Teas Petition To Revive Received |
| 2025-05-06 | Petition To Revive-Granted |
| 2025-05-06 | Notice Of Revival - E-Mailed |
| 2025-05-06 | Sou Extension Received With Teas Petition |
| 2025-04-08 | Sou Extension 2 Filed |
| 2024-11-11 | Abandonment - No Use Statement Filed |
| 2024-11-11 | Abandonment Notice Mailed - No Use Statement Filed |
| 2024-10-08 | Sou Extension 1 Filed |
| 2024-04-09 | Noa Mailed - Sou Required From Applicant |
| 2024-02-13 | Published For Opposition |
| 2024-02-13 | Official Gazette Publication Confirmation E-Mailed |
| 2024-01-24 | Notification Of Notice Of Publication E-Mailed |
| 2024-01-09 | Assigned To Examiner |
| 2024-01-09 | Approved For Pub - Principal Register |
| 2023-09-26 | Assigned To Lie |
| 2023-09-26 | Applicant/Correspondence Changes (Non-Responsive) Entered |
| 2023-09-26 | Preliminary/Voluntary Amendment - Entered |
| 2023-05-08 | New Application Office Supplied Data Entered |
| 2023-05-05 | Teas Voluntary Amendment Received |
| 2023-04-18 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2023-04-18 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2023-04-18 | Teas Change Of Correspondence Received |
| 2023-04-17 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Pharmaceutical preparations for the treatment of inflammation and inflammatory diseases; therapeutic antibodies for human use for the treatment of inflammation and inflammatory diseases; Pharmaceutical preparations for the treatment of cancer; therapeutic antibodies for human use for the treatment of cancer
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 5 Apr 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.